Nutanix (NTNX) proposed sale: 144,707 shares ($11.06M)

Nutanix, Inc. reported a proposed sale of 144,707 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $11,059,204.05.

Rhea-AI Filing Summary

Nutanix, Inc. reported a proposed sale of 144,707 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $11,059,204.05. The filing lists the approximate sale date as 10/02/2025 on NASDAQ. The shares to be sold were acquired from multiple compensation events: performance shares granted on 03/15/2024 (14,346 shares) and 09/15/2024 (89,394 shares), restricted stock grants on 03/15/2024 (25,159 shares) and 09/15/2025 (2,318 shares), an employee purchase on 03/20/2024 (741 shares) paid in cash, and additional performance shares on 09/15/2025 (12,749 shares). The filing states no securities were sold by the person in the prior three months and includes the standard representation about no undisclosed material adverse information.

Insights

Corporate Governance Analyst

TL;DR: Insider intends to sell 144,707 shares (~0.054% of outstanding shares) via Morgan Stanley on 10/02/2025.

The Form 144 discloses a planned sale of 144,707 Nutanix common shares with an aggregate market value of $11,059,204.05. The shares originate from recent compensation awards and an employee purchase, indicating the source is company grants rather than open-market purchases.

This filing is a regulatory disclosure of a proposed insider sale rather than an executed transaction; it notifies investors of potential forthcoming supply but does not itself confirm trade execution or motive.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale does the Nutanix (NTNX) Form 144 disclose?

The filing discloses a proposed sale of 144,707 common shares with an aggregate market value of $11,059,204.05 to occur approximately on 10/02/2025.

Who is the broker handling the proposed NTNX sale?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York, NY.

What is the source of the shares being sold in the NTNX Form 144?

Shares were acquired mainly as performance shares and restricted stock from the issuer on dates including 03/15/2024, 09/15/2024, and 09/15/2025, plus an employee purchase on 03/20/2024.

Did the filer report any sales of Nutanix securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

How many shares outstanding does the Form 144 list for Nutanix?

The filing lists 268,800,007 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001483009
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NUTANIX, INC.
SEC File Number	001-37883
Address of Issuer	1740 Technology Drive, Suite 150 San Jose CALIFORNIA 95110
Phone	408-216-8360
Name of Person for Whose Account the Securities are To Be Sold	RAJIV RAMASWAMI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	144707	11059204.05	268800007	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Performance Shares	ISSUER			14346	03/15/2024	Not Applicable
Common	09/15/2024	Performance Shares	ISSUER			89394	09/15/2024	Not Applicable
Common	09/15/2025	Restricted Stock	ISSUER			2318	09/15/2025	Not Applicable
Common	03/15/2024	Restricted Stock	ISSUER			25159	03/15/2024	Not Applicable
Common	03/20/2024	Employee Stock Purchase Plan	ISSUER			741	03/20/2024	Cash
Common	09/15/2025	Performance Shares	ISSUER			12749	09/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/02/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rajiv Ramaswami
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)